Showing results (1841-1850 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|June 1, 1993
Use and toxicity of the colony-stimulating factorsJ R Schriber, R S Negrin
Drug Safety|March 13, 2002
Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?Laurence G Howes, Diane Tran
Drug Safety|March 13, 2002
Cost-benefit analysis of the detection of prescribing errors by hospital pharmacy staffPatrica M L A van den Bemt, Maarten J Postma, Eric N van Roon, et al.
Drug Safety|October 1, 1993
Adverse effects of coumarin anticoagulantsG F Pineo, R D Hull
Drug Safety|February 19, 2021
Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety SignalsFlorence van Hunsel, Laura Peters, Helga Gardarsdottir, et al.
Drug Safety|February 23, 2021
Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug EventsSonam N Shah, Roseann S Gammal, Mary G Amato, et al.
Drug Safety|February 12, 2021
Anticholinergic Activity of Psychotropic Drugs and Cognitive Impairment Among Participants Aged 45 and Over: The CONSTANCES StudyAbdelkrim Ziad, Claudine Berr, Fabrice Ruiz, et al.
Drug Safety|September 26, 2019
Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic ReviewsEmanuel Raschi, Matteo Bianchin, Milo Gatti, et al.
Drug Safety|October 21, 2018
Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular DevelopmentNadezda Abramova, Julie Hubbard, Joan Schertz, et al.
Drug Safety|March 5, 2019
Established and Emerging Immunological Complications of Biological Therapeutics in Multiple SclerosisBabak Soleimani, Katy Murray, David Hunt
Pageof 309